Ignacio Bazo-Gil - Publications

PD-1/PD-L1 Blockers in NSCLC Brain Metastases: Challenging Paradigms and Clinical Practice.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 02, 2020

Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network.

Journal: Cancer research

Published: May 14, 2018

KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target.

Journal: Molecular cancer

Published: October 15, 2017

Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 26, 2015

Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis.

Journal: Journal of translational medicine

Published: April 22, 2015

Epidermal Growth Factor Receptor targeting in non-small cell lung cancer: revisiting different strategies against the same target.

Journal: Current drug targets

Published: August 08, 2014

Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed.

Journal: Journal of translational medicine

Published: November 03, 2013

Safety and efficacy of maintenance therapy with a nonspecific cytochrome P17 inhibitor (CYP17i) after response/stabilization to docetaxel in metastatic castration-resistant prostate cancer.

Journal: Clinical genitourinary cancer

Published: October 05, 2012

Novel translational strategies in colorectal cancer research.

Journal: World journal of gastroenterology

Published: November 09, 2007